La Forgia et al. (2020) [17] proposed a radiomics-based approach using CESM to predict multiple biomarkers, including ER, PR, HER2, Ki-67, tumor grade, and triple-negative (TN) status. This evidence concerns the gene ERBB2 and neoplasm.